When DNA is damaged, cellular processes respond and repair the DNA. Inhibiting DNA damage repair can be therapeutically beneficial in cancers with genetic vulnerabilities related to DNA damage response. Scientists at St. Jude Children's Research Hospital have uncovered a mechanism behind how this process works, which may have implications for cancer treatment. The results were published today in…
Bristol Myers Squibb is facing one problem after another with its autoimmune CAR-T therapy program. The company says it has figured out the cause of the safety signal in a lupus trial ...
The Federal Government has ordered stricter enforcement of Ebola screening protocols at all points of entry into Nigeria to prevent cross-border transmissi Read More…
(MedPage Today) -- Taking the nonhormonal dual neurokinin (NK) receptor antagonist elinzanetant (Lynkuet) at bedtime did not result in residual daytime sleepiness and actually improved sleepiness…
